G6PD Deficiency Safety Lookup

A fast, evidence-based reference for people with G6PD deficiency and their families. Search any item, then check what to ask your physician or pharmacist.

Last reviewed: May 2026. Emergency numbers vary by country — in the US call 911; otherwise call your local emergency number.

Last reviewed: May 2026 (next review: May 2027) • Sources include CPIC pharmacogenetic guidelines, NIH/MedlinePlus, WHO, AAP, NCBI Bookshelf, and peer-reviewed literature.

This resource is educational and does not replace care from a licensed clinician or pharmacist.

Most people with G6PD deficiency live normal, healthy lives.

The goal is not to fear every food, medication, or supplement. The goal is to know the proven triggers, ask the right questions, and act quickly if warning signs appear.

Risk level
Type

51 results

Rasburicase

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Strongly oxidizing drug; can cause severe, sometimes fatal hemolysis and methemoglobinemia. FDA contraindicated in G6PD deficiency.
Symptoms to monitor
Dark urine, jaundice, shortness of breath, bluish skin within hours of infusion.
What to ask your doctor / pharmacist
Is there an alternative for tumor lysis prevention (e.g., allopurinol)?

Last updated: May 2026

Pegloticase

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Same oxidative mechanism as rasburicase. Contraindicated in G6PD deficiency.
Symptoms to monitor
Hemolysis and methemoglobinemia within hours.
What to ask your doctor / pharmacist
Can we use allopurinol or febuxostat for gout instead?
Source
FDA label; CPIC.

Last updated: May 2026

Primaquine

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Antimalarial that causes dose-dependent hemolysis. Standard doses can be severe in Class I–II deficiency.
Symptoms to monitor
Dark urine, jaundice, anemia 1–3 days after dose.
What to ask your doctor / pharmacist
Can I use atovaquone-proguanil or doxycycline for malaria instead? Should I be screened first?

Last updated: May 2026

Tafenoquine

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Single-dose antimalarial. FDA requires G6PD testing before use due to severe hemolysis risk.
Symptoms to monitor
Prolonged hemolysis due to long drug half-life.
What to ask your doctor / pharmacist
Have I had quantitative G6PD testing? Is there a safer option?

Last updated: May 2026

Dapsone

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Causes dose-dependent hemolysis and methemoglobinemia even in mild deficiency at therapeutic doses.
Symptoms to monitor
Bluish lips or skin, dark urine, fatigue, shortness of breath.
What to ask your doctor / pharmacist
Is there a non-sulfone alternative for my condition?

Last updated: May 2026

Methylene blue

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Paradoxically worsens methemoglobinemia and causes hemolysis in G6PD deficiency.
Symptoms to monitor
Worsening cyanosis, dark urine, shortness of breath — seek emergency care.
What to ask your doctor / pharmacist
What alternative treatment will you use for methemoglobinemia given my G6PD status?

Last updated: May 2026

Nitrofurantoin

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Common UTI antibiotic consistently reported to cause hemolysis in G6PD deficiency.
Symptoms to monitor
Dark urine, fatigue, jaundice within days of starting.
What to ask your doctor / pharmacist
Can I have fosfomycin or a cephalosporin for my UTI instead?
Source
Youngster 2010; Luzzatto, NEJM 2018.

Last updated: May 2026

Sulfamethoxazole / TMP-SMX

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Sulfonamide antibiotic (brands include Bactrim and Septra) with well-documented hemolysis risk in G6PD deficiency.
Symptoms to monitor
Hemolysis 1–3 days after starting.
What to ask your doctor / pharmacist
Can you prescribe a non-sulfa antibiotic (e.g., amoxicillin, doxycycline, cephalexin)?

Last updated: May 2026

Phenazopyridine (Pyridium)

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Urinary analgesic that causes methemoglobinemia and hemolysis.
Symptoms to monitor
Bluish skin, dark urine, weakness.
What to ask your doctor / pharmacist
Is there a safer way to manage UTI bladder pain?

Last updated: May 2026

Sulfadoxine-pyrimethamine (Fansidar)

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Antimalarial combination with documented hemolysis risk.
Symptoms to monitor
Hemolysis within 24–72 hours.
What to ask your doctor / pharmacist
Can I use a non-sulfa malaria prevention drug?

Last updated: May 2026

Nalidixic acid

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Older quinolone antibiotic with well-documented hemolysis in G6PD deficiency. On the WHO and BNF avoid lists.
Symptoms to monitor
Dark urine, jaundice within 1–3 days of starting.
What to ask your doctor / pharmacist
Can a different antibiotic class be used instead?

Last updated: May 2026

Toluidine blue (surgical/dental staining)

Medication

Evidence of harm: Moderate
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Same oxidant class as methylene blue; can trigger hemolysis even at the small doses used for tissue staining.
Symptoms to monitor
Hemolysis and methemoglobinemia within hours.
What to ask your doctor / pharmacist
Will any blue dye be used during my procedure? Please confirm it is not toluidine or methylene blue.
Source
Anesthesia case reports; StatPearls.

Last updated: May 2026

Vitamin K3 (menadione/menadiol — older synthetic forms)

Medication

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Synthetic menadione can cause hemolysis, especially in newborns. Modern vitamin K1 (phytonadione) used in standard newborn care is safe.
Symptoms to monitor
Neonatal jaundice and hemolysis if old formulations are used.
What to ask your doctor / pharmacist
Please confirm any vitamin K given is phytonadione (K1), not menadione.

Last updated: May 2026

Sulfasalazine

Medication

Evidence of harm: Moderate
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Sulfa drug; risk is dose-related. Often tolerated at low doses but monitor closely.
Symptoms to monitor
Anemia symptoms within days of dose increase.
What to ask your doctor / pharmacist
Should we start at a low dose and check my CBC and reticulocyte count?

Last updated: May 2026

Ciprofloxacin and other fluoroquinolones

Medication

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Listed as risky on older lists; clinical evidence is mixed and mostly from older case reports. Often used safely with monitoring.
Symptoms to monitor
Watch for dark urine, fatigue, jaundice.
What to ask your doctor / pharmacist
Is a non-quinolone antibiotic available for my infection?
Source
Youngster 2010; recent infectious disease reviews.

Last updated: May 2026

Aspirin (high dose)

Medication

Evidence of harm: Moderate
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Hemolysis reported mostly at very high doses (>1 g/day) or in severe (Class I) variants. Standard low-dose aspirin (81 mg) is generally tolerated.
Symptoms to monitor
Symptoms only at high doses: pallor, dark urine, fatigue.
What to ask your doctor / pharmacist
Is the dose I'm taking safe given my G6PD status?

Last updated: May 2026

Chloroquine / hydroxychloroquine

Medication

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Historically listed as risky; modern reviews suggest standard antimalarial and rheumatologic doses are usually tolerated in non-severe (Class III) deficiency. Severe (Class I–II) variants warrant closer monitoring.
Symptoms to monitor
Hemolysis is uncommon at standard doses; watch for dark urine, fatigue, jaundice.
What to ask your doctor / pharmacist
What CBC monitoring do I need on this drug, and is my G6PD class known?

Last updated: May 2026

Quinine / quinidine

Medication

Evidence of harm: Moderate
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Reported triggers especially at high antimalarial doses. Tonic water exposure is not a meaningful risk.
Symptoms to monitor
Hemolysis at therapeutic doses.
What to ask your doctor / pharmacist
Is there a safer antimalarial or antiarrhythmic?

Last updated: May 2026

Isoniazid (INH)

Medication

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Occasionally reported as a trigger; usually tolerated for TB treatment.
Symptoms to monitor
Watch for fatigue, jaundice during TB therapy.
What to ask your doctor / pharmacist
What is the routine TB monitoring schedule for me?
Source
BNF; case reports.

Last updated: May 2026

Glibenclamide / glyburide

Medication

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Sulfonylurea; case reports of hemolysis. Other diabetes drugs are often preferred.
Symptoms to monitor
Anemia symptoms with new dose.
What to ask your doctor / pharmacist
Is metformin or another non-sulfonylurea better for me?
Source
Meloni 1992; case series.

Last updated: May 2026

Acetaminophen (paracetamol)

Medication

Evidence of harm: Moderate
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Often listed online as risky, but high-quality studies do not show meaningful hemolysis at recommended therapeutic doses. Generally the preferred analgesic and fever reducer in G6PD deficiency. Overdose can still cause hemolysis (and liver injury) — stay within label dosing.
Symptoms to monitor
Routine medication monitoring at therapeutic doses.
What to ask your doctor / pharmacist
What is the right dose for me or my child, and what is the daily maximum?

Last updated: May 2026

Ibuprofen and other NSAIDs

Medication

Evidence of harm: Moderate
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Old lists include NSAIDs, but systematic reviews find no consistent hemolysis signal at standard doses.
Symptoms to monitor
Routine NSAID side effects only.
What to ask your doctor / pharmacist
Is short-course NSAID use okay for me?

Last updated: May 2026

Penicillins and cephalosporins

Medication

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Standard antibiotics with no meaningful G6PD hemolysis signal in modern reviews. Not appropriate if you have a known penicillin or cephalosporin allergy — tell your clinician.
Symptoms to monitor
Standard antibiotic side effects only.
What to ask your doctor / pharmacist
Confirm there are no sulfa or nitrofurantoin components in my prescription, and that I'm not allergic to this class.

Last updated: May 2026

Azithromycin, doxycycline

Medication

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Generally considered safe alternatives to sulfa drugs for many infections from a G6PD standpoint. Note: doxycycline has age (typically avoided in young children) and pregnancy restrictions unrelated to G6PD — confirm with your clinician.
Symptoms to monitor
Standard side effects only.
What to ask your doctor / pharmacist
Is this a good substitute for a sulfa antibiotic given my age and other conditions?

Last updated: May 2026

Routine vaccines

Medication

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Routine childhood and adult vaccinations are safe and recommended. Infections that vaccines prevent are themselves common hemolysis triggers.
Symptoms to monitor
Standard post-vaccine soreness or low fever.
What to ask your doctor / pharmacist
Are we up to date on recommended vaccines?
Source
AAP; CDC.

Last updated: May 2026

Fava beans (broad beans, ful, Vicia faba)

Food

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Contain vicine and convicine, which create strong oxidative stress in red blood cells. Cause classic 'favism.'
Symptoms to monitor
Dark urine, jaundice, fatigue, fever within 24–48 hours of eating.
What to ask your doctor / pharmacist
Are there hidden fava ingredients in this food (bean flours, mixed-bean dishes)?

Last updated: May 2026

Fava bean pollen (inhaled near flowering plants)

Food

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Rare reports of hemolysis from inhalation in highly sensitive individuals (Class I variants).
Symptoms to monitor
Same as eating fava beans.
What to ask your doctor / pharmacist
Should I avoid being near flowering fava fields if I'm severely deficient?
Source
Arese 1998; case reports.

Last updated: May 2026

Bitter melon (Momordica charantia)

Food

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Contains vicine-like compounds; isolated case reports of hemolysis, particularly from the seeds. Cooked flesh in normal culinary amounts has not been clearly linked to harm.
Symptoms to monitor
Dark urine, jaundice, fatigue within 24–48 hours.
What to ask your doctor / pharmacist
Should I avoid bitter melon seeds and concentrated supplements?
Source
Basch 2003; Raman 1996 case reports.

Last updated: May 2026

Tonic water (quinine)

Food

Evidence of harm: Weak
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Quinine in tonic water is far below medical antimalarial doses. No reliable evidence that tonic water triggers hemolysis.
Symptoms to monitor
None expected at normal intake.
What to ask your doctor / pharmacist
Is occasional tonic water okay?

Last updated: May 2026

Soy, peanuts, lentils, chickpeas (non-fava legumes)

Food

Evidence of harm: Strong
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Often listed online; no reliable evidence of hemolysis. Generally safe.
Symptoms to monitor
Routine food tolerance only.
What to ask your doctor / pharmacist
Confirm I do not need to avoid all legumes — only fava beans.

Last updated: May 2026

Vitamin C–rich foods (oranges, kiwi, berries)

Food

Evidence of harm: Strong
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Listed on some sites because of antioxidant content (misinterpretation). Dietary vitamin C is safe.
Symptoms to monitor
None expected.
What to ask your doctor / pharmacist
Is normal fruit intake fine?

Last updated: May 2026

Balanced diet (fruits, vegetables, whole grains, lean protein)

Food

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Supports overall health. No special G6PD diet is needed beyond avoiding fava beans.
Symptoms to monitor
What to ask your doctor / pharmacist
Any specific nutrients I should focus on?

Last updated: May 2026

Good hydration

Food

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Helps protect kidneys during any hemolytic event.
Symptoms to monitor
What to ask your doctor / pharmacist
How much fluid is right for me daily?

Last updated: May 2026

Henna (especially on newborn skin)

Herb/Supplement

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Lawsone (the active dye) is oxidizing. Severe hemolysis reported in G6PD-deficient infants after skin application.
Symptoms to monitor
Jaundice and pallor in infants within 24–48 hours.
What to ask your doctor / pharmacist
Confirm no henna or 'natural dye' is being used on my baby's skin.
Source
Raupp 2001; Kandil 1996 (PubMed).

Last updated: May 2026

High-dose intravenous vitamin C (pharmacologic doses, typically ≥15 g IV)

Herb/Supplement

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Pharmacologic IV doses (commonly 15–100 g, e.g., in oncology or 'wellness' infusions) can cause severe, sometimes fatal hemolysis and acute kidney injury. Standard hospital doses (1–2 g IV) have not been clearly linked to hemolysis but should still be cleared with your clinician.
Symptoms to monitor
Dark urine, jaundice, back/flank pain within hours — seek emergency care.
What to ask your doctor / pharmacist
Has G6PD been confirmed before any high-dose IV vitamin C infusion? What is the planned dose?
Source
Quinn 2017; Rees 1993; Mehta 2021 case reports.

Last updated: May 2026

Oral vitamin C (normal supplement doses, up to ~500 mg/day)

Herb/Supplement

Evidence of harm: Moderate
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Standard oral doses are generally considered safe; the problem is specifically high-dose IV infusions.
Symptoms to monitor
Routine only.
What to ask your doctor / pharmacist
Is my supplement dose within the safe oral range?
Source
NIH ODS; reviews.

Last updated: May 2026

Alpha-lipoic acid (high dose)

Herb/Supplement

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Case reports of hemolysis with high-dose use.
Symptoms to monitor
Anemia symptoms after dose increases.
What to ask your doctor / pharmacist
Is this supplement necessary for me?
Source
Bast 2008; case reports.

Last updated: May 2026

Berberine (goldenseal, Coptis, Berberis)

Herb/Supplement

Evidence of harm: Moderate
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Berberine displaces bilirubin from albumin and is linked to neonatal jaundice risk. Avoid in infants and pregnancy.
Symptoms to monitor
Jaundice, especially in neonates.
What to ask your doctor / pharmacist
Are any of my supplements berberine-based?

Last updated: May 2026

Traditional herbal mixes containing camphor, naphthalene, borneol, or unidentified dyes

Herb/Supplement

Evidence of harm: Moderate
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Multiple case series link traditional preparations of uncertain composition (especially infant tonics and topical balms) to hemolysis. Risk is highest in newborns and infants.
Symptoms to monitor
Jaundice, dark urine, pallor — seek urgent care, especially in infants.
What to ask your doctor / pharmacist
Can a pharmacist or clinician review every ingredient in this product before I or my child uses it?
Source
Chan 1993 (Hong Kong infants); McGann 2013 review.

Last updated: May 2026

N-acetylcysteine (NAC)

Herb/Supplement

Evidence of harm: Moderate
Often Listed — Weak Evidence
This item appears on some internet lists, but current evidence does not clearly support routine avoidance at normal exposure levels.
Why it matters
Sometimes listed as risky; actually used safely (and as an antioxidant) in many G6PD patients.
Symptoms to monitor
Routine only.
What to ask your doctor / pharmacist
Is NAC fine at my dose?
Source
PubMed reviews.

Last updated: May 2026

Folic acid

Herb/Supplement

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Helpful for red blood cell production, especially during or after a hemolytic episode.
Symptoms to monitor
What to ask your doctor / pharmacist
Do I need a folate supplement?
Source
NIH ODS.

Last updated: May 2026

Vitamin E (normal doses)

Herb/Supplement

Evidence of harm: Weak
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Antioxidant; small studies suggest a potential supportive role. Use normal doses, not megadoses.
Symptoms to monitor
What to ask your doctor / pharmacist
What is a reasonable daily vitamin E dose?
Source
Eldamhougy 1988; reviews.

Last updated: May 2026

Mothballs / naphthalene (clothing, closets, diapers)

Treatment

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Potent trigger. Even storing baby clothes with mothballs has caused severe hemolysis in G6PD-deficient infants.
Symptoms to monitor
Hemolysis within 24–48 hours of exposure.
What to ask your doctor / pharmacist
Is my home, daycare, or relative's home free of mothballs?

Last updated: May 2026

Camphor balms, oils, vapor rubs (on skin or nostrils)

Treatment

Evidence of harm: Moderate
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Reports of hemolysis, especially in infants. Avoid camphor products in young children with G6PD deficiency.
Symptoms to monitor
Hemolysis and separate camphor toxicity (seizures in children).
What to ask your doctor / pharmacist
Are there camphor-free alternatives for cough or muscle pain?
Source
AAP; case reports.

Last updated: May 2026

Topical methylene blue (umbilical or wound dyes — historical)

Treatment

Evidence of harm: Strong
Avoid
Do not use unless a qualified clinician determines the benefit outweighs the risk and monitoring is in place.
Why it matters
Can be absorbed through skin and trigger hemolysis.
Symptoms to monitor
Hemolysis.
What to ask your doctor / pharmacist
Confirm no methylene blue is used in any procedure or dressing.
Source
StatPearls.

Last updated: May 2026

Hyperbaric oxygen therapy (HBOT)

Treatment

Evidence of harm: Weak
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
High oxygen exposure increases oxidative stress; a small number of case reports describe hemolysis in G6PD-deficient patients. Discuss with hematology before HBOT.
Symptoms to monitor
Dark urine, fatigue, jaundice during or after therapy.
What to ask your doctor / pharmacist
Has hematology cleared me for HBOT, and what monitoring will be done during sessions?
Source
Mychaskiw 2001; Yousaf 2018 case reports.

Last updated: May 2026

Acute infection or illness (fever, sepsis, viral illness)

Treatment

Evidence of harm: Strong
Use Caution
Use only after discussing your G6PD status, dose, and monitoring plan with your clinician or pharmacist.
Why it matters
Infection is the single most common trigger of hemolysis in G6PD deficiency — more common than food or medication. Always tell the clinician treating an infection that you have G6PD deficiency so they avoid sulfa drugs, nitrofurantoin, and other triggers.
Symptoms to monitor
Dark/cola-colored urine, jaundice, pallor, or extreme fatigue during an illness — seek urgent medical care.
What to ask your doctor / pharmacist
Given my G6PD deficiency, which antibiotic or antiviral is safest for this infection?

Last updated: May 2026

Routine surgery and anesthesia

Treatment

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Most modern anesthetics are safe. Inform the anesthesia team — they will avoid drugs like prilocaine and large doses of benzocaine that can cause methemoglobinemia.
Symptoms to monitor
Routine surgical monitoring.
What to ask your doctor / pharmacist
Will the anesthesia team avoid prilocaine, large-dose benzocaine, and methylene blue?
Source
AAGBI; anesthesia reviews.

Last updated: May 2026

Blood transfusion (during severe hemolysis)

Treatment

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Lifesaving in severe hemolytic anemia. Standard donor blood is appropriate.
Symptoms to monitor
What to ask your doctor / pharmacist
What hemoglobin level would trigger a transfusion for me?
Source
Hematology guidelines.

Last updated: May 2026

Phototherapy for neonatal jaundice

Treatment

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
First-line treatment for jaundice in G6PD-deficient newborns. Safe and effective.
Symptoms to monitor
Close bilirubin monitoring.
What to ask your doctor / pharmacist
What bilirubin level requires phototherapy for my baby?

Last updated: May 2026

Exchange transfusion (severe neonatal jaundice)

Treatment

Safety evidence
Generally Considered Safe
Generally considered safe when used appropriately, but individual needs may vary — confirm with your clinician or pharmacist.
Why it matters
Used when bilirubin is very high or rising fast despite phototherapy.
Symptoms to monitor
Standard NICU monitoring.
What to ask your doctor / pharmacist
At what bilirubin level would my baby need exchange transfusion?

Last updated: May 2026

5 Things to Always Avoid

Fava beans

Broad beans, ful, Vicia faba, bean flours.

High-risk medicines

Rasburicase, pegloticase, primaquine, tafenoquine, dapsone, methylene blue, nitrofurantoin, sulfamethoxazole, phenazopyridine.

Mothballs / naphthalene

Especially dangerous for infants and children.

Henna on infant skin

Linked to severe hemolysis in G6PD-deficient newborns.

High-dose IV vitamin C

Especially wellness or oncology infusions without G6PD screening.

How to read the categories

  • AvoidStrong evidence of hemolysis risk. Do not use unless a clinician decides benefit clearly outweighs risk and monitors closely.
  • Use CautionReal but variable risk. Often dose-dependent or only risky in severe (Class I) deficiency. Ask your physician or pharmacist.
  • Often Listed — Weak EvidenceOften listed online as risky, but high-quality studies do not show clear harm at normal exposures. Discuss with your clinician before changing anything.
  • Generally Considered SafeReasonable, evidence-based options that are generally considered safe for people with G6PD deficiency when used appropriately.